Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00542750 · ClinicalTrials.gov registry record · Phase 1
An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents
A Phase 1 study of Cannabis Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00542750: Completed Phase 1 study of Cannabis Dependence, sponsored by Medical University of South Carolina.
NCT00542750 is a Phase 1 study of Cannabis Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 24 participants, below the 129-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00542750, a Phase 1 study of Cannabis Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to determine the feasibility of conducting a trial of N-Acetylcysteine in cannabis dependent adolescents.
Primary Outcome
Feasibility of recruiting and retaining participants during the study period. This is the primary outcome of interest for this proof-of-concept feasibility preliminary study.
Conditions Studied
Interventions
- DRUG N-Acetylcysteine
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
What the finished NCT00542750 record still lists
NCT00542750 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 129-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Cannabis Dependence appearing as the primary indexed condition, and to 1 intervention - of which N-Acetylcysteine is the first listed.
NCT00542750 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT00542750 about?
NCT00542750 is a clinical study titled "An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents". The purpose of this pilot study is to determine the feasibility of conducting a trial of N-Acetylcysteine in cannabis dependent adolescents.
What is the current status of trial NCT00542750?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-01. Estimated completion is 2008-12.
What conditions does trial NCT00542750 study?
This clinical trial studies the following conditions: Cannabis Dependence.
What interventions are being tested in trial NCT00542750?
The interventions under investigation include: N-Acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT00542750?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00542750 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00542750's enrollment target sits among peer trials
24 11th of 12 higher than 2 of 12 other Cannabis Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
COMPLETED · Phase 1
-
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
RECRUITING
-
Neuroimaging of Adolescent Cannabis Use Treatment
RECRUITING · NA
-
Breathwork-assisted Treatment for Cannabis Use Disorder
ACTIVE NOT RECRUITING · NA
-
Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine
COMPLETED · Phase 4
-
Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia